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Minerals are one of the components of food, though they are not synthesized in the body but they are essential
for optimal health. Several essential metals are required for the proper functioning of many enzymes, transcriptional
factors and proteins important in various biochemical pathways. For example Zn, Mg and Mn are cofactors of
hundreds of enzymes, and Zn is involved in the synthesis and secretion of insulin from the pancreatic beta-cells.
Similarly, Cr enhances the insulin receptor activity on target tissues, especially in muscle cells. Insulin is the key
hormone required to maintain the blood glucose level in normal range. In case of insulin deficiency or resistance,
blood glucose concentration exceeds the upper limit of the normal range of 126 mg/dl. Persistent increase of blood
serum glucose level leads to overt chronic hyperglycemia, which is a major clinical symptom of diabetes mellitus.
Poor glycemic control and diabetes alters the levels of essential trace elements such as Zn, Mg, Mn, Cr, Fe etc. by
increasing urinary excretion and their concomitant decrease in the blood. Hence, the main purpose of this review is
to discuss the important roles of essential trace elements in normal homeostasis and physiological functioning.
Moreover, perturbation of essential trace elements is also discussed in perspective of type 2 diabetes pathobiology.
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Metals and type 2 diabetes (T2D)
Metals are naturally occurring inorganic elements which
are present in very small amounts in the living tissues but
are important for the vital processes of life [1]. Some
metals (e.g. magnesium) are known as macro-metals and
are found in high amount in the body tissues, therefore
they are also called macro-nutrients [2]. At least 100 mg
of each macro-nutrient is required in the daily diet [3]. In
contrast, some metals e.g. copper (Cu), zinc (Zn), iron
(Fe) and manganese (Mn), chromium (Cr) etc. are needed
in the body in very small amounts, less than 100 parts per
million (ppm), hence, these are called trace elements or
micro-nutrients [4]. Metals are involved in a range of
physiological processes such as prosthetic groups of many
proteins, water balance, cofactors of many enzymes etc.
[5]. Several metals function as part of proteins/enzymes
as metalloproteinase/metalloenzymes [6]. Such proteins
without metal containing prosthetic groups are unable to
perform their physiological functions [7]. The regulation
of various metallic contents in the body is pre-requisite* Correspondence: awan.fr@gmail.com
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reproduction in any medium, provided the orfor their proper functioning [8]. Metals enable the muscles
to contract or relax, and also transmit impulses through
the nerves. Most metals are available in the soluble salt
forms, which regulate the composition of biofluids. The
proper metabolic functioning of the trace elements de-
pends on their normal levels in various body tissues [9].
Due to the diversified metabolic characteristics and func-
tions; various metals such as Mg, Zn, Cr, Fe, Mn and Cu
are considered as essential for normal human health [1].
Several studies have reported that the imbalance of
some essential metals might adversely affect pancreatic
islet and cause development of diabetes [10]. It is also
manifested that some reactive oxygen species (ROS) are
produced during diabetes due to imbalance of essential
metals. This oxidative stress might decrease the insulin
gene promoter activity and mRNA expression in pancre-
atic islet cells due to hyperglycemic condition [11-13].
On contrary to essential metals, some toxic metals
have also been identified which accumulate in various
biological samples of T2D patients. Uncontrolled pollu-
tion and industrialization might be a potential source to
expose human population against toxic metals such as
lead (Pb), nickel (Ni), cadmium (Cd) and arsenic (As).
Some of the toxic metals are implicated to disrupt thetral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nism in glucose regulation [14,15].
Essential metals and their physiological roles
Iron (Fe)
Iron (Fe) is an essential transition metal required for the
synthesis of two important functional proteins such as
hemoglobin and myoglobin, which are involved in the
transport of molecular oxygen during respiration [16]. It is
also required in the elastin production along with Zn and
ascorbic acid and collagen synthesis [17]. In blood stream
small fraction of serum Fe is transported by a glycoprotein,
called transferrin into the cells [18]. In the body tissues,
ferritin stores free Fe, which is increased in newly diag-
nosed diabetic subjects [19,20]. Jiang et al. manifested
higher level of ferritin in diabetics as compared to the
non-diabetic subjects. Recently, a report showed a positive
correlation between serum ferritin and Fe deposition in
tissues, which linearly increased with diabetes duration
[21]. The serum ferritin elevation is regarded as an index
of Fe overload, which successively leads to a condition
called hemochromatosis [22]. Several studies showed asso-
ciation between hemochromatosis and type 2 diabetes
(T2D) [23-25]. The elevated Fe level oxidizes various bio-
molecules such as nucleic acids, proteins and lipids, which
may contribute to T2D development by decreasing insulin
secretion from pancreatic beta cells with concomitant
increase of insulin resistance [13,26-29]. Previous studies
[30,31] manifested a strong relationship between serum
ferritin level and insulin resistance at preclinical stage prior
to the development of full blown diabetes mellitus. Re-
garding this, studies also suggested that in addition to the
glucose elevation, serum ferritin level might become a sur-
rogate marker of diabetes to predict disease onset [32,33].
Magnesium (Mg)
Mg is the most abundant macro-nutrient which is essen-
tial for the maintenance of proper health. It is required
for the activity of more than 300 enzymes, which serve
several important physiological functions in the human
body [34]. Mg containing enzymes are involved in the
glucose homeostasis, nerve transmission, DNA and RNA
production [35].
In prospective cohort studies an association was inves-
tigated between Mg consumption through diet and the
risk of type 2 diabetes. Furthermore, it was demon-
strated that Mg deficiency might lead to a decrease in
insulin mediated glucose uptake [34,36]. On the other
hand, Mg supplementation prevented insulin resistance
and also reduced the development of diabetes in animal
models [37]. Some studies reported low level of Mg in
the blood serum and an increased urinary excretion of
Mg in the diabetics relative to their healthy control
subjects [36].Manganese (Mn)
Mn acts as a cofactor in several enzymes including those
involved in bone marrow production, and metabolism of
carbohydrates, proteins and fats [38]. It is essential for the
proper utilization of choline, thiamine, biotin, vitamin C
and vitamin E. Mn as a cofactor of enzymes is also
involved in mitochondrial glycoproteins synthesis [15].
Impaired activity of these enzymes, due to Mn defi-
ciency leads to abnormal cartilage production [39]. Mn is
also a cofactor of pyruvate carboxylase, which plays a role
in the conversion of various non-carbohydrate com-
pounds into glucose via gluconeogenesis for their subse-
quent use. In short, Mn is also required for normal insulin
synthesis, its secretion, and an alteration in its metabolism
has been implicated in diabetes development [1]. Very
recently, in an elegant study by Forte and colleagues
reported Mn deficiency in type 2 diabetic patients with
respect to their control subjects [40].
Copper (Cu)
Cu is another essential mineral, which is needed for
several biological functions. It is required for the catalytic
activity of superoxide dismutase (SOD) that participates in
the protection of cells from superoxide radicals [41]. Cu
imbalance is implicated in cholesterol elevation by dis-
rupting normal high density lipoproteins (HDL) and low
density lipoproteins (LDL) balance [42]. Cu also activates
cytochrome oxidase which is involved in the electron
transport chain of the mitochondria [43]. In case of cop-
per deficiency, cytochrome oxidase reduces its activity
which might lead to the distortion of mitochondria in
metabolically active tissues such as pancreatic acinar cells,
hepatocytes etc. [44,45].
Published data show that Cu deficiency is one of the
reasons for the development of cardiovascular diseases
[46]. Other reports suggest that Cu is also beneficial to
prevent arthritis associated inflammation and epilepsy
[47]. More recently, it has been reported that disturbances
in copper levels in various biofluids and tissues are asso-
ciated with abnormalities implicated in metabolic path-
ways of diabetes and its complications [1,48]. Copper as
well as zinc metals play roles in order to protect oxidative
damage of body tissues [49,50].
Zinc (Zn)
Zinc (Zn) is an essential trace element which is required
for normal cell processing e.g. cell division and apop-
tosis. Zn participates in multiple biochemical pathways
such as in transcription, translation and cell divisions
[51]. More than 300 enzymes need Zn for their catalytic
activities. On the other hand, removal of Zn from cata-
lytic site leads to the loss of enzymatic activity [52].
About 70% of the Zn is bound to albumin and any
pathological alteration of albumin affects the serum Zn
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disorders including the dermal, gastrointestinal, neuro-
logical and immunological abnormalities [54].
Recently, published studies revealed that type 2 dia-
betic patients have suboptimal Zn status in blood due to
its increased urinary depletion [1,40]. As a result, hypo-
zincemia and hyperzincuria are developed in diabetics
[1,54]. Zn plays a key role in the storage and secretion of
insulin, which subsequently increases the uptake of glu-
cose [1,55]. The decreased plasma level of Zn adversely
affects the ability of islet cells to produce and secrete
insulin [55,56].
It is well established that Zn transporter (ZnT8) is a
key protein for the regulation of insulin secretion from
the pancreatic β-cells. Recently a mutation in ZnT8
transporter has been associated with T2D [57]. Briefly all
these evidences show the importance of Zn in the main-
tenance and integration of insulin hexamer and its role
in the metabolic regulation [55].
Chromium (Cr)
The biological activity of Cr depends on its valence state
and chemical complexes it forms [9,58,59]. Trivalent form
of Cr has high biological activity which is required for the
optimal glucose uptake by cells [59,60]. Cr regulates insu-
lin and blood glucose levels by stimulating insulin signal-
ing pathway and metabolism by up-regulating glucose
transporter (GLUT4) translocation in muscle cells [61].
Cr deficiency results in the elevation of blood glucose
levels and if it is persisted for a prolonged period, it may
lead to the development of diabetes [62]. Some reports
show that Cr supplements decrease the blood sugar level
in diabetes [63]. Prolonged hyperglycemia increases Cr
urinary excretion [1,40].
Briefly, cumulative evidences indicate the essential
nature of these metals for the maintenance of human
normal physiology. While their imbalance predisposes to
glucose intolerance which subsequently converts to
diabetes related complications [1].
Toxic metals and health
Toxic metals e.g. lead (Pb), nickel (Ni), cadmium (Cd) and
arsenic (As) deposit in tissues and are non-degradable.
Hence, these metals remain in the tissues for a long period,
and it is often difficult to eliminate metal-based problem.
Body tissues can tolerate a certain level of metals, and
beyond such threshold limits tissues get damaged due to
metal toxicity. Some of the toxic metals including Ni, As
etc. are manifested as carcinogens [11,64,65].
The mechanism of metal induced carcinogenesis is
elusive, which might be due to complex nature of interac-
tions of metals in biological systems [11]. Furthermore,
essential metals also have carcinogenic effects if present in
excess amounts than they are required. For example, Cr3+is essential while Cr4+ behaves as carcinogenic agent [64].
Similarly, hemochromatosis increases the risk of hepato-
carcinoma [66]. Preponderance of these toxic metals in
the environment is potentially alarming and harmful for
human health [67]. They are common in the nature and
present in air, water and soil, which increases the proba-
bility of human exposure [15].
Toxic metals react with various proteins in the body
that may modify their functions and kinetics. Moreover,
when diet is low in essential metals, the body absorbs
and makes use of more toxic metals. In the current
environmental conditions several human populations are
exposed to high levels of toxic metals including Pb, Cd,
As and Ni [65]. An abundance of a toxic metal competes
with essential metal for enzymes activity and various
body physiological functions [68]. For example, Zn is
required for the activity of many enzymes. In case of Zn
deficiency and increased exposure to toxic metals such
as lead (Pb), body will use Pb instead of Zn [69].
Some toxic metals including Pb, Cd, As and Ni are
elevated in biological samples of diabetic patients, which
adversely affect health status of an individual by disrup-
ting organ physiology and functions. Free Pb in blood
plasma is rapidly transferred to soft body tissues [70].
Lead (Pb)
Some toxic metals including Pb were reported in higher
concentration in the biological samples (i.e. blood plasma
and urine) of diabetics than the non-diabetics [71]. Pb is
hazardous to most of the human body organs, and inter-
feres with metabolism and cellular functions [72]. Previous
reports showed a linear relationship between blood Pb level
and renal dysfunction in age-related diseases. This may be
due to the frequent exposure to environmental Pb [73].
Studies demonstrated that exposure to Pb badly affects
the antioxidant pathways [65]. Existing evidences indi-
cate that metal induced toxicity may cause derangement
of antioxidant mechanisms in living tissues; as a con-
sequence highly reactive oxygen species (ROS) are gen-
erated. This antioxidant imbalance might lead to the
degradation of proteins, nucleic acids and lipid peroxida-
tion. An oxidative attack of cellular components by ROS
is implicated in the pathogenesis of several human
diseases including diabetes [14,74].
Cadmium (Cd)
Cd is a heavy metal which is widely detected in environ-
ment such as air, water and soil. Increased Cd level in
water is absorbed by plants, animals and humans [70].
Frequent exposure to Cd contributes to its excess accu-
mulation in kidney, which results in renal damage and
nephropathy [14]. Furthermore, Cd high level reduces
calcium absorption, which becomes an impending cause
of bone and kidney losses, called Itai-Itai disease. It has
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transporter-4 (GLUT4) translocation by insulin and en-
hanced the induction of pancreatic beta cells’ disruption
in diabetes [75].
Arsenic (As)
Arsenic is a naturally occurring deadly semi-metal, which
is mainly used in copper alloys and lead batteries. As is
also used in the insecticides, herbicides and pesticides
production. Ground water contamination with arsenic is
becoming an alarming threat for human lives thoughout
the world [11,71]. Frequent exposure to arsenic linked to
various diseases including certain types of cancers and
diabetes. Previous studies indicate that As implicates in
the disruption of glucose metabolism due to an alteration
in cell signaling tranduction factors such as tumor necro-
sis factor-α (TNF-α), mitogen-activated protein kinase
(MAPK) etc., subsequently GLUT4 translocation to mem-
brane might be arrested. Some studies manifest the
connection of arsenic in beta-cell dysfunction [14,75].
Nickel (Ni)
Ni is ferromagnetic element which is mostly used in Ni-Cd
batteries. Most of the human populations are exposed to
Ni through different means such as drinking polluted
water, air and eating nickel contaminated food [76]. It has
been observed that kidney is the major organ for Ni accu-
mulation, thus contributes in renal dysfunction [77]. Most
recently, Forte et al. found that type 2 diabetic patients
have 0.89 ng/ml of Ni in the blood relative to 0.77 ng/ml in
the control subjects [40].
Briefly, investigators have analyzed various biofluids
such as blood serum/plasma, hair, urine etc. in order to
know the altered metabolism of metals in various diseases
including diabetes. Among these biological samples, urine
was unique because it is readily available and non-
invasively sampled. In some previously published studies,
researchers have shown urinary levels of metals which
correspond to their blood serum status of this metal
[1,14]. Aforementioned studies showed the existence of
link between the levels of toxic metals and essential trace
metals [78].
Conclusion
From published literature on derangement of metals in
diabetes, it could be concluded that normal levels of
essential metals are disturbed in T2D patients. The status
of essential trace elements in various body tissues is in-
fluenced by renal excretion. Alteration in the level of one
metal may influence normal levels of other metals. It can
also be suggested that toxic metals such as Pb, Ni and Cd
may have a role to induce renal tubular dysfunction in
diabetic subjects. Subsequently dysfunctional kidneys may
become a potential source for the loss of several essentialtrace elements through urine voiding rather than their
retention in blood plasma /serum in order to retain the
homeostasis of blood and other tissues. The high urinary
excretion of Zn results in its reduced levels in blood
plasma/serum which is the sign of disruptions in Zn based
antioxidant mechanism. Therefore, in future large popu-
lation based prospective studies on urinary analysis of
various essential and toxic metals, may help to have scien-
tific as well as practical implications in understanding and
controlling diabetes or its complications like diabetic
nephropathy.
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